These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11544374)

  • 1. Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction.
    Kozlowski LT; Strasser AA; Giovino GA; Erickson PA; Terza JV
    Tob Control; 2001 Sep; 10(3):201-3. PubMed ID: 11544374
    [No Abstract]   [Full Text] [Related]  

  • 2. Smokers making a quit attempt using e-cigarettes with or without nicotine or prescription nicotine replacement therapy: Impact on cardiovascular function (ISME-NRT) - a study protocol.
    Klonizakis M; Crank H; Gumber A; Brose LS
    BMC Public Health; 2017 Apr; 17(1):293. PubMed ID: 28376818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco smoking, harm reduction, and nicotine product regulation.
    Britton J; Edwards R
    Lancet; 2008 Feb; 371(9610):441-5. PubMed ID: 17920116
    [No Abstract]   [Full Text] [Related]  

  • 4. Smoking cessation: integrating recent advances into clinical practice.
    Coleman T
    Thorax; 2001 Jul; 56(7):579-82. PubMed ID: 11413360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation in cardiovascular patients.
    Stefanatou A
    Hellenic J Cardiol; 2008; 49(6):422-31. PubMed ID: 19110929
    [No Abstract]   [Full Text] [Related]  

  • 6. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.
    Batra A; Klingler K; Landfeldt B; Friederich HM; Westin A; Danielsson T
    Clin Pharmacol Ther; 2005 Dec; 78(6):689-96. PubMed ID: 16338284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine-environmental risk factors for initiation. Two principles, one host.
    Bickel WK
    Nicotine Tob Res; 1999; 1 Suppl 2():S109-10. PubMed ID: 11768165
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis.
    Coleman T; Chamberlain C; Cooper S; Leonardi-Bee J
    Addiction; 2011 Jan; 106(1):52-61. PubMed ID: 21054620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association.
    Piano MR; Benowitz NL; Fitzgerald GA; Corbridge S; Heath J; Hahn E; Pechacek TF; Howard G;
    Circulation; 2010 Oct; 122(15):1520-44. PubMed ID: 20837898
    [No Abstract]   [Full Text] [Related]  

  • 10. Public Health England publishes e-cigarette review.
    Burki TK
    Lancet Oncol; 2018 Mar; 19(3):e150. PubMed ID: 29456090
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of nicotine replacement therapy during hospitalization.
    Emmons KM; Goldstein MG; Roberts M; Cargill B; Sherman CB; Millman R; Brown R; Abrams DB
    Ann Behav Med; 2000; 22(4):325-9. PubMed ID: 11253444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine replacement therapy as a smoking cessation aid among disadvantaged smokers: What answers do we need?
    Paul C; Wolfenden L; Tzelepis F; Yoong S; Bowman J; Wye P; Sherwood E; Rose S; Wiggers J
    Drug Alcohol Rev; 2016 Nov; 35(6):785-789. PubMed ID: 26661119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.
    Joseph AM; Norman SM; Ferry LH; Prochazka AV; Westman EC; Steele BG; Sherman SE; Cleveland M; Antonuccio DO; Hartman N; McGovern PG
    N Engl J Med; 1996 Dec; 335(24):1792-8. PubMed ID: 8943160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of long-term nicotine use: An ongoing debate].
    Dupont P; Benyamina A; Aubin HJ
    Rev Mal Respir; 2016 Dec; 33(10):892-898. PubMed ID: 27242286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for smoking cessation during pregnancy.
    Benowitz N; Dempsey D
    Nicotine Tob Res; 2004 Apr; 6 Suppl 2():S189-202. PubMed ID: 15203821
    [No Abstract]   [Full Text] [Related]  

  • 16. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of nicotine replacement therapies (NRT): a critique of current practice.
    McNeill A; Foulds J; Bates C
    Addiction; 2001 Dec; 96(12):1757-68. PubMed ID: 11784468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine replacement therapy effect on pregnancy outcomes.
    Forinash AB; Pitlick JM; Clark K; Alstat V
    Ann Pharmacother; 2010 Nov; 44(11):1817-21. PubMed ID: 20978216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to reduce harm from continued tobacco use.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005231. PubMed ID: 17636791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
    Grief SN
    Prim Care; 2011 Mar; 38(1):23-39. PubMed ID: 21356419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.